United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dicloxacillin sodium capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug (see clinical pharmacology – susceptibility  testing ) . dicloxacillin may be used to initiate therapy in suspected cases of resistant stap

United States - English - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules usp and other antibacterial drugs, dicloxacillin sodium capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug. (see clinical pharmacology – susceptibility plate testing ). dicloxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal i

Israel - English - Ministry of Health

a.l. medi-market ltd. - cloxacillin as sodium - powder for solution for inj/inf - cloxacillin as sodium 500 mg/vial - cloxacillin - cloxacillin is indicated for the treatment of sensitive staphylococcal infections:respiratory infections, otorhinolaryngologic infections, renal infections, urogenital infections, neuro-meningeal infections, bone and joint infections, endocarditis, and treatment of skin infections caused by sensitive staphylococci and/or streptococci.cloxacillin is also indicated as preventive treatment of postoperative infections in neurosurgery.

Israel - English - Ministry of Health

a.l. medi-market ltd. - cloxacillin as sodium - powder for solution for inj/inf - cloxacillin as sodium 1000 mg/vial - cloxacillin - cloxacillin is indicated for the treatment of sensitive staphylococcal infections: respiratory infections, otorhinolaryngologic infections, renal infections, urogenital infections, neuro-meningeal infections, bone and joint infections, endocarditis, and treatment of skin infections caused by sensitive staphylococci and/or streptococci. cloxacillin is also indicated as preventive treatment of postoperative infections in neurosurgery.

Ireland - English - HPRA (Health Products Regulatory Authority)

athlone laboratories ltd - flucloxacillin sodium - capsule, hard - 500 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - flucloxacillin sodium - film-coated tablet - flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - flucloxacillin sodium - film-coated tablet - flucloxacillin

Malta - English - Medicines Authority

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - flucloxacillin - granules for oral solution - flucloxacillin 125 mg/5ml - antibacterials for systemic use

Malta - English - Medicines Authority

novelgenix therapeutics limited 20, oliver business park, oliver road, park royal, london, nw10 7jb, united kingdom - flucloxacillin sodium - powder for oral solution - flucloxacillin sodium 250/5 milligram(s) - antibacterials for systemic use

Malta - English - Medicines Authority

novelgenix therapeutics limited 20, oliver business park, oliver road, park royal, london, nw10 7jb, united kingdom - flucloxacillin sodium - powder for oral solution - flucloxacillin sodium 125/5 milligram(s)/millilitre - antibacterials for systemic use